MIDHANI Q1 FY27: Consol PAT +27% YoY to ₹16.5 Cr, OPM Slips to ~15% from ~20%
PAT +27% YoY · revenue +40.47% · margins compressing · miss vs street
₹239.49 Cr
+40.47% YoY
₹16.47 Cr
+27% YoY
6.6%
-0.7pp YoY
₹0.88
MIDHANI's consolidated Q1 FY27 PAT rose 27.0% YoY to ₹16.47 Cr (standalone ₹16.31 Cr, +27.4% YoY per the company's own press release) on consolidated revenue of ₹239.49 Cr, up 40.5% YoY — both metrics running ahead of management's guided pace of 15% revenue and 20% PAT growth over the next two years. Even so, the quarter fell short of the pre-result Street-implied revenue range of ₹300-350 Cr, landing roughly 20-30% below the low end despite the strong YoY jump; EBITDA of ₹46.60 Cr (+12.9% YoY) translated to a margin of ~19.5% on a press-release basis, at the low end of the ~19-21% range flagged pre-result. No formal third-party Street consensus specific to this quarter turned up in search, so the read here leans on our own pre-result preview and management's own guidance.
Q1 FY-2027 vs prior quarters
The real story is margin, not growth. Operating margin (EBITDA less other income, over revenue from operations) compressed to ~15.3% from ~20.0% a year ago and ~21.0% last quarter, while net margin fell to 6.6% of total income from 7.3% YoY — well short of management's own 24-25% FY27 EBITDA margin target. The squeeze sits on the cost side: total expenses grew 42.2% YoY to ₹225.56 Cr, outpacing 40.5% revenue growth, with employee costs up 15.8% YoY and other expenses up 13.9% YoY as the key drivers, alongside a swing in the inventory-change line (₹-20.87 Cr this quarter vs ₹-70.80 Cr a year ago). QoQ, both revenue (-56.7%) and PAT (-78.9%) fell sharply from Q4 FY26 (₹552.75 Cr revenue, ₹77.90 Cr PAT), but Q4 is a seasonally loaded quarter for this PSU (year-end execution and billing), so the sequential drop reads as seasonal, not deterioration.
The stock went into the print at ₹421.2, up 1.1% over the past month of trading.
Management provided strong forward-looking guidance, projecting a 15% year-on-year increase in top-line revenue and a corresponding 20% increase in the bottom line over the next 2 years, with EBITDA margins expected to be between 24%-25%. They also indicated a plan for approximately INR 1,000 crores in capex over the n
— This quarter: missed
Order book stood at ₹2,329 Cr as of July 1, 2026, roughly in line with the ₹2,290 Cr flagged in our pre-result preview and tracking management's stated aim of ~₹1,500 Cr in fresh FY26-27 bookings. No exceptional items appear in either the current or year-ago quarter, so the growth print is clean with no one-off distortion, and the consolidated result includes only a ₹0.15 Cr equity-method profit share from the pre-operational Utkarsha Aluminium JV, keeping standalone and consolidated numbers within 1% of each other. Going into Q2, the margin trajectory against the 24-25% FY27 target — not the topline growth rate, which is already running ahead of guidance — is the metric to watch.
W1
EBITDA margin trajectory toward management's 24-25% FY27 target — Q1 print ~15.3%-19.5% depending on metric, well below
W2
Fresh order inflows against the ~₹1,500 Cr FY26-27 booking target — order book ₹2,329 Cr as of July 1, 2026
W3
Capex execution against the ₹1,000 Cr 3-year plan and progress on the 'metal bank' initiative (₹2,000 Cr revenue target within 3 years)
Margin Test Ahead: Defence Orders Steady, Cost Inflation in Focus
With a ₹2,290 cr order book and 20% revenue growth guidance, MIDHANI enters Q1 FY27 on bullish footing. The Street debates near-term margin pressure against medium-term capex-enabled recovery.
MIDHANI reports Q1 FY27 results on August 12, with a robust order book (₹2,290 cr) and 20% full-year revenue guidance anchoring expectations. Yet the Street's near-term debate centers on margins: Q4 FY26 saw EBITDA margins compress 222 bps to 19.8% due to raw material cost inflation and a less favorable product mix. The key question for Q1 is whether cost pressures have stabilized—and whether the company can steer toward higher-margin special alloys ahead of its ₹1,000 cr capex ramp.
What to Expect
~₹300–350 Cr
In line with 20% FY27 growth guidance; compares to ~₹275 Cr in Q1 FY26
~19–21%
Near-term pressure likely; Q4 FY26 was 19.8%; relief depends on product mix and commodity costs
₹2,290 Cr
Plus ₹1,100 Cr pipeline; provides multi-year revenue visibility and confidence in defence demand
~65–70%
Core driver; indigenization tailwinds (jet engines, missiles, aerospace alloys) support volume growth
A strong Q1 would show revenue in the upper half of ₹300–350 Cr with EBITDA margins stable or rising on favorable mix (higher-value superalloys, titanium specialties). PAT growth should exceed 15% YoY. A weak Q1 would print below ₹300 Cr revenue or margins sub-19%, signaling prolonged cost headwinds or order execution delays. The Street looks for capex progress updates (automation, titanium, single-crystal blade materials).
On Track?
MIDHANI has delivered steady order inflows despite defence capex cycles, and FY26 revenues rose 12.5% (to ~₹1,209 Cr) with PAT up 19%. However, margins lagged: EBITDA growth (10.7%) trailed revenue, indicating cost pressures are real. The company's FY27 guidance (20% revenue growth) is ambitious; if realised, it would mark an acceleration. The capex ramp (₹1,000 Cr over 3 years) is the vehicle for margin recovery—but payoff is medium-term (FY27–FY28). Q1 will be watched for evidence that the company is managing input costs and shifting product mix upward.
What the Street Says
Since Last Quarter
Aug 1: GM (Production) Shri Anand Kumar Kaluvala retired. Routine transition in a PSU; no operational impact flagged. Jun 5: New Government Nominee Director appointed (Shri Prakash Rajpurohit replaces Shri Amit Satija). Board composition change in line with government shareholding rights. May 29: FY26 final results approved; ₹1.25 dividend per share recommended (12.5% payout). Strong capital return posture. May 27: Regulatory fine (₹4.95L each, BSE and NSE) for Q4 FY26 board composition non-compliance under SEBI LODR. Non-material; company has not yet paid. Jun 25: Trading window closed for Q1 FY27 results (standard SEBI compliance). Summary: Routine governance and compliance events; no material business risk or opportunity flagged in recent filings.
What to Watch on Result Day
1 · EBITDA Margin Trajectory
Is Q1 margin at or above Q4 FY26's 19.8%? Any commentary on cost inflation normalization or product mix improvement? This is the linchpin for Street conviction on 200 bps capex-driven recovery by year-end.
2 · New Defence Orders & Pipeline
Any fresh large orders announced? Updates on ₹1,100 Cr pipeline conversion? Defence indigenization orders (e.g., new aero-engine, missile alloys) would reinforce medium-term growth story and offset near-term margin skepticism.
3 · Capex Execution & Titanium Scale
Progress on ₹1,000 Cr automation / titanium expansion / single-crystal blade development? Management commentary on timeline to margin recovery will shape FY27 guidance credibility and Street re-rating.
MIDHANI enters Q1 FY27 with tailwinds (robust defence order book, indigenous capex, government support) but headwinds (cost inflation, margin compression). The Street remains bullish on 12–18 month returns (target ₹464–487), yet consensus is split on near-term margin pressure. August 12 results will either confirm that cost normalization is underway—resetting margin recovery expectations upward—or extend the cautious posture through Q2. Watch the three items above closely; weak margins paired with slowing capex progress could trigger downgrades, while stable-to-improving margins and brisk order inflows would re-accelerate bullish momentum into the festive season defence sector ramp.